These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21148526)

  • 21. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
    Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
    Tanywe A; Fernandez RS
    JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buruli ulcer caused by "Mycobacterium ulcerans subsp. shinshuense".
    Watanabe T; Ohkusu K; Nakanaga K; Ishii N; Nakashima K; Shindo M; Yoshida Y; Yamamoto O
    Eur J Dermatol; 2010; 20(6):809-10. PubMed ID: 20822972
    [No Abstract]   [Full Text] [Related]  

  • 24. Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
    Almeida D; Converse PJ; Ahmad Z; Dooley KE; Nuermberger EL; Grosset JH
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e933. PubMed ID: 21245920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
    Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
    Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HIV infection and Mycobacterium ulcerans disease in Benin.
    Johnson RC; Nackers F; Glynn JR; de Biurrun Bakedano E; Zinsou C; Aguiar J; Tonglet R; Portaels F
    AIDS; 2008 Apr; 22(7):901-3. PubMed ID: 18427211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.
    Phillips RO; Sarfo FS; Abass MK; Abotsi J; Wilson T; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2014; 58(2):1161-6. PubMed ID: 24323473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
    Ruf MT; Sopoh GE; Brun LV; Dossou AD; Barogui YT; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1334. PubMed ID: 21980547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A Papua New Guinean with three foot ulcers].
    Coenders A; Verregghen M; Baerends EP
    Ned Tijdschr Geneeskd; 2018; 162():D2295. PubMed ID: 29372678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report.
    Phanzu DM; Ablordey A; Imposo DB; Lefevre L; Mahema RL; Suykerbuyk P; Meyers WM; Portaels F
    Am J Trop Med Hyg; 2007 Dec; 77(6):1099-102. PubMed ID: 18165530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of patients with buruli ulcer after surgical treatment with or without antimycobacterial treatment in Ghana.
    Schunk M; Thompson W; Klutse E; Nitschke J; Opare-Asamoah K; Thompson R; Fleischmann E; Siegmund V; Herbinger KH; Adjei O; Fleischer B; Loscher T; Bretzel G
    Am J Trop Med Hyg; 2009 Jul; 81(1):75-81. PubMed ID: 19556570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients.
    O'Brien DP; Friedman D; Hughes A; Walton A; Athan E
    Intern Med J; 2017 Sep; 47(9):1011-1019. PubMed ID: 28585259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
    Ruf MT; Schütte D; Chauffour A; Jarlier V; Ji B; Pluschke G
    Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium ulcerans disease in the middle belt of Ghana: An eight-year review from six endemic districts.
    Adu EJ; Ampadu E
    Int J Mycobacteriol; 2015 Jun; 4(2):138-42. PubMed ID: 26972882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
    Johnson RC; Sáez-López E; Anagonou ES; Kpoton GG; Ayelo AG; Gnimavo RS; Mignanwande FZ; Houezo JG; Sopoh GE; Addo J; Orford L; Vlasakakis G; Biswas N; Calderon F; Della Pasqua O; Gine-March A; Herrador Z; Mendoza-Losana A; Díez G; Cruz I; Ramón-García S
    Trials; 2022 Jul; 23(1):559. PubMed ID: 35804454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form.
    Abalos FM; Aguiar J; Guédénon A; Portaels F; Meyers WM
    Ann Diagn Pathol; 2000 Dec; 4(6):386-90. PubMed ID: 11149971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
    Amoussouhoui AS; Sopoh GE; Wadagni AC; Johnson RC; Aoulou P; Agbo IE; Houezo JG; Boyer M; Nichter M
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006291. PubMed ID: 29529087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection.
    Pommelet V; Vincent QB; Ardant MF; Adeye A; Tanase A; Tondeur L; Rega A; Landier J; Marion E; Alcaïs A; Marsollier L; Fontanet A; Chauty A
    Clin Infect Dis; 2014 Nov; 59(9):1256-64. PubMed ID: 25048846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.
    Walsh DS; Eyase F; Onyango D; Odindo A; Otieno W; Waitumbi JN; Bulimo WD; Schnabel DC; Meyers WM; Portaels F
    Am J Trop Med Hyg; 2009 Dec; 81(6):1110-3. PubMed ID: 19996445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice.
    Chauffour A; Robert J; Veziris N; Aubry A; Jarlier V
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005066. PubMed ID: 27755552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.